Stockfacts
Explore
Use Cases
Docs
Pricing
English
Log in
Sign up free
Overview
Financials
Trends
Transcripts
Options
Institutions
Insiders
Corporate Actions
SEC Filings
RGEN
REPLIGEN CORP
CIK 0000730272 · Nasdaq
Nasdaq
Health Care
Biological Products, (No Diagnostic Substances)
$143.94
↑ 6.53 (4.75%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read:
Neutral
Overall score · based on 4/4 lenses
Fundamentals
Ownership
Technicals
Options
Bullish: Ownership; Risks: Options
Key stats
Market Cap
$8.12B
P/E Ratio
157.97
EPS
0.87
Dividend Yield
Not covered
52W Position
57%
Beta
1.26
Valuation multiples
Fwd P/E
71.94
PEG
2.25
P/B
3.86
P/S
10.64
EV/Revenue
10.59
ROE
2.4%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).
Price · 1Y
251 trading days
End-of-day close, not real-time intraday
52-Week Range
Position 57%
$100.99
$175.77
Latest Financials
2025-12-31 FY
Revenue
$738.26M
Net Income
$48.89M
Total Assets
$2.95B
Free Cash Flow
$93.90M
Recent news